6.55
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TLRY Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.14
Aprire:
$6.07
Volume 24 ore:
5.51M
Relative Volume:
1.47
Capitalizzazione di mercato:
$761.28M
Reddito:
$858.28M
Utile/perdita netta:
$-1.34B
Rapporto P/E:
-0.4795
EPS:
-13.6608
Flusso di cassa netto:
$-75.96M
1 W Prestazione:
+0.15%
1M Prestazione:
-13.82%
6M Prestazione:
-59.32%
1 anno Prestazione:
+0.55%
Tilray Brands Inc Stock (TLRY) Company Profile
Nome
Tilray Brands Inc
Settore
Telefono
519.322.8800
Indirizzo
655 MADISON AVENUE, NEW YORK
Compare TLRY vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TLRY
Tilray Brands Inc
|
6.55 | 761.28M | 858.28M | -1.34B | -75.96M | -13.66 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.74 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
117.94 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
9.93 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.08 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
564.81 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Canaccord Genuity | Hold |
| 2024-04-05 | Reiterato | Alliance Global Partners | Neutral |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-29 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Iniziato | Barclays | Underweight |
| 2021-11-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Ripresa | Cowen | Outperform |
| 2021-05-07 | Ripresa | Jefferies | Buy |
| 2021-05-06 | Iniziato | Canaccord Genuity | Buy |
| 2021-04-28 | Ripresa | BofA Securities | Buy |
| 2021-02-18 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-11-11 | Downgrade | Stifel | Hold → Sell |
| 2020-10-01 | Reiterato | MKM Partners | Neutral |
| 2020-09-21 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-05-12 | Reiterato | The Benchmark Company | Buy |
| 2020-04-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-04-09 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-13 | Iniziato | BofA/Merrill | Neutral |
| 2019-11-13 | Reiterato | The Benchmark Company | Buy |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Reiterato | Piper Jaffray | Overweight |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-08-14 | Reiterato | The Benchmark Company | Buy |
| 2019-07-17 | Iniziato | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Iniziato | Consumer Edge Research | Overweight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Iniziato | Oppenheimer | Perform |
| 2019-05-15 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Iniziato | Alliance Global Partners | Neutral |
Mostra tutto
Tilray Brands Inc Borsa (TLRY) Ultime notizie
Cannabis Stocks To Watch NowApril 5th - MarketBeat
Tilray Brands, Inc. (NASDAQ:TLRY) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Q3 2026 Tilray Brands Inc Earnings Call Transcript - GuruFocus
Top Cannabis Stocks To Watch NowApril 4th - MarketBeat
Forget Tilray: This Boring Dividend Beast Is a Much Savvier Play - AOL.com
Do Record Q3 Results And New Hard Beverages Change The Bull Case For Tilray Brands (TLRY)? - simplywall.st
Why Tilray Brands shares are surging in Wednesday's premarket - MSN
Top Cannabis Stocks To Add to Your WatchlistApril 3rd - MarketBeat
Tilray Brands, Inc. (NASDAQ: TLRY) Q3 2026 earnings call transcript - MSN
Is Tilray Brands, Inc. (TLRY) among the 11 best marijuana stocks to buy right now? - MSN
Tilray Brands, Inc. (NASDAQ:TLRY) Q3 2026 Earnings Call Transcript - Insider Monkey
TLRY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Tilray Brands acquires BrewDog’s US assets - MSN
Tilray Brands in charts: FQ3 segmental revenues see double-digit increase Y/Y, except alcohol slumps 24% - MSN
Tilray Brands (TSE:TLRY) Shares Up 6.9%Should You Buy? - MarketBeat
Cannabis Stocks on Track for Best Week of 2026. Here’s Why. - Barron's
Tilray Brands (NASDAQ:TLRY) Stock Price Up 6.7% Following Analyst Upgrade - MarketBeat
ATB Cormark Capital Markets Issues Pessimistic Forecast for Tilray Brands (NASDAQ:TLRY) Stock Price - MarketBeat
FinancialContentTilray Brands Surges on Record $207 Million Q3 Revenue: Margin Recovery in Beverages and German Cannabis Growth Signal Turnaround - FinancialContent
Tilray Brands Is Looking Better (NASDAQ:TLRY) - Seeking Alpha
Tilray rebounds as Roth Capital upgrades to buy after Q3 results - MSN
Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish - Yahoo! Finance Canada
Cannabis Stocks To Watch TodayApril 2nd - MarketBeat
Tilray stock upgraded at Roth after Q3 results (TLRY:NASDAQ) - Seeking Alpha
Tilray Stock Continues To Climb After Earnings Beat, Record RevenueTilray Brands (NASDAQ:TLRY) - Benzinga
This Brinker Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
+5.05% for Tilray stock as Q3 performance impresses but bearish signals limit upside - Traders Union
Tilray's Beverage Segment Weighed Down by Softer Industry Demand -- Market Talk - Moomoo
Tilray Brands, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Stock Rating Upgraded by Roth Mkm - MarketBeat
TLRY: Roth Capital Upgrades Tilray Brands to Buy Rating | TLRY S - GuruFocus
Should Tilray Brands Be in Your Portfolio Post Q3 Earnings? - Yahoo Finance
Tudor Investment Corp ET AL Purchases New Position in Tilray Brands, Inc. $TLRY - MarketBeat
A Look At Tilray Brands (TLRY) Valuation After New Beverage Deals And Australian Medical Cannabis Expansion - Yahoo Finance
TLRY stock drops premarket: Why analysts are mixed despite upbeat Q3 report - MSN
Roth/MKM upgrades Tilray stock on international growth, cost savings By Investing.com - Investing.com India
Tilray Brands reaffirms outlook after record quarter - MSN
Roth/MKM upgrades Tilray stock on international growth, cost savings - Investing.com
Tilray Earnings: Beverage Results Are a Drag on Otherwise Solid Performance From Cannabis - morningstar.com
TLRY Stock Price, Quote & Chart | TILRAY BRANDS INC (NASDAQ:TLRY) - ChartMill
Why Tilray Brands Shares Are Surging In Wednesday's Premarket - Sahm
TLRY stock jumps on revenue beat, international growth – retail eyes upside reversal after 30% slide this year - MSN
Tilray Brands, Inc. (TLRY) Stock Forecasts - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Trading Down 5.1%Here's Why - MarketBeat
Tilray Brands Inc (TLRY) Q3 2026 Earnings Call Highlights: Recor - GuruFocus
Tilray Brands Inc. stock falls Wednesday, underperforms market - MarketWatch
Tilray Brands, Inc. (TLRY) sees a more significant dip than broader market: Some facts to know - MSN
Tilray reports $206.7M revenue, $(0.24) EPS; improved operating and net loss - TradingView
Tilray's International Business Surge Sparks Rally — Retail Eyes ‘Upside Reversal’ After 30% Slide This Year - Stocktwits
Tilray Brands (NASDAQ: TLRY) boosts sales and sharply cuts losses - Stock Titan
Tilray Brands Q3 Fiscal 2026 Financial Review - AlphaStreet
Tilray Brands Inc Azioni (TLRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tilray Brands Inc Azioni (TLRY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SIMON IRWIN D | President and CEO |
Jul 31 '25 |
Option Exercise |
0.58 |
706,216 |
409,605 |
5,200,788 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
970,279 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
742,069 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Buy |
0.58 |
6,000 |
3,496 |
698,287 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
874,564 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 30 '25 |
Option Exercise |
0.61 |
261,194 |
159,328 |
919,069 |
| Herhalt Johann Michael | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
239,930 |
| Looney Thomas P. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
354,416 |
| Hopkinson David G. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
335,563 |
| Clanachan David F | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
236,880 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):